The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver.
UDP-glucuronosyltransferases (UGTs) are critical for the metabolism and clearance of drugs, chemicals, and hormones. The development of UGT1A1 and 1A6 was studied in 50 pediatric liver samples using bilirubin, serotonin activity assays, and Western blot as well as pharmacokinetic scaling. UGT activity developed age dependently in pediatric liver. Maximal activity of 0.7690 nmol · min · (-1) mg protein(-1) was observed for UGT1A1 at 3.8 months. For UGT1A6, activity matured at 14 months (4.737 nmol · min · (-1)mg protein(-1)). Protein expression was not age-dependent, and activities did not correlate to protein levels for either enzyme. The in vitro activities were used to calculate normalized hepatic clearances using both allometric scaling and a physiologically based pharmacokinetic model. For UGT1A1, allometry predicted normalized adult clearances of 0.0070 l · h(-1) · kg(-1) at 3.0 (well stirred) and 2.8 years (parallel tube), whereas the Simcyp model showed normalized clearances of 0.0079 l · h(-1) · kg(-1) at 2.6 (well stirred) and 2.5 years (parallel tube). For UGT1A6, only the Simcyp well stirred model converged at 0.3524 l · h(-1) · kg(-1) at 12.6 months. These data imply independent regulation of UGT1A1 and 1A6 where activity has matured after 6 months to 1 year. Total hepatic clearance of substances mediated by these enzymes may mature concurrently or take longer because of other physiological factors. Late development of UGT enzymes may contribute to chemical, drug, and environmental toxicity.
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Mānoa, 651 Ilalo St., BSB 320, Honolulu, HI 96813, USA.
Shogo J
SJ
Miyagi
Abby C
AC
Collier
D000293:Adolescent; D000328:Adult; D000375:Aging; D001663:Bilirubin / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D005260:Female; D014453:Glucuronosyltransferase / Q000378:metabolism*; D006801:Humans; D007223:Infant; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D008297:Male; D008962:Models, Theoretical; D012701:Serotonin / Q000378:metabolism*; D017366:Serotonin Receptor Agonists / Q000378:metabolism*; D062367:ortho-Aminobenzoates / Q000378:metabolism; D000099148:UGT1A1 Enzyme
D001663:Bilirubin; D014453:Glucuronosyltransferase; D012701:Serotonin; D017366:Serotonin Receptor Agonists; D062367:ortho-Aminobenzoates; D000099148:UGT1A1 Enzyme; C031385:anthranilic acid; C110655:UDP-glucuronosyltransferase, UGT1A6
AAPS PharmSci. 2002;4(1):E4
12049488
Biochem J. 1981 Apr 15;196(1):257-60
6796071
Clin Pharmacokinet. 2006;45(9):931-56
16928154
Eur J Clin Invest. 2003 Nov;33(11):988-97
14636303
Drug Metab Rev. 2006;38(3):393-409
16877259
Mol Pharmacol. 1988 Dec;34(6):729-35
3143908
Biochem Pharmacol. 2002 Feb 1;63(3):409-19
11853692
Drug Metab Dispos. 2004 Nov;32(11):1201-8
15304429
Biochem Pharmacol. 2006 May 28;71(11):1531-9
16455060
Drug Metab Dispos. 2006 Dec;34(12):2097-101
16985101
J Biochem Mol Toxicol. 2007;21(4):169-75
17936930
Drug Metab Dispos. 2007 Jan;35(1):139-49
17062778
Methods Enzymol. 2005;400:104-16
16399346
Biochemistry. 1998 Aug 4;37(31):11018-25
9692996
J Clin Endocrinol Metab. 2001 Jun;86(6):2734-42
11397879
Biochemistry. 2000 Sep 26;39(38):11540-52
10995221
Clin Pharmacokinet. 1999 Dec;37(6):485-505
10628899
Drug Metab Dispos. 2008 Dec;36(12):2405-9
18775982
Gut. 2002 Feb;50(2):259-65
11788570
Dev Pharmacol Ther. 1989;13(2-4):70-7
2515047
Biochem J. 1972 Sep;129(3):605-18
4658989
Carcinogenesis. 2005 Dec;26(12):2172-8
16051636
Drug Metab Rev. 1999 Nov;31(4):817-99
10575553
J Clin Anesth. 1992 Jan-Feb;4(1):4-10
1540367
Biochem Pharmacol. 1994 Apr 29;47(9):1469-79
8185657
Biochim Biophys Acta. 2007 Nov;1770(11):1557-66
17764847
Am J Prev Med. 2009 Sep;37(3):181-7
19666156
Life Sci. 1989;44(18):1251-8
2716470
Pediatrics. 2003 Jun;111(6 Pt 1):1358-66
12777553
Regul Toxicol Pharmacol. 2005 Jun;42(1):64-9
15896444
Drug Metab Dispos. 2007 Sep;35(9):1587-92
17556526
Methods Enzymol. 2005;400:57-75
16399343
Drug Metab Pharmacokinet. 2009;24(1):25-36
19252334
Br J Clin Pharmacol. 2001 Jul;52(1):77-83
11453893
Toxicol Lett. 2000 Mar 15;112-113:333-40
10720749
Clin Pharmacokinet. 2009;48(6):371-85
19650676
Drug Metab Dispos. 2003 Jan;31(1):133-9
12485962